Published in Clin Diagn Lab Immunol on May 01, 1995
Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet (1992) 11.38
Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell (1993) 10.83
Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell (1991) 7.40
Clinical implications of the p53 tumor-suppressor gene. N Engl J Med (1993) 7.29
Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene (1994) 7.24
Retinoic acid regulates aberrant nuclear localization of PML-RAR alpha in acute promyelocytic leukemia cells. Cell (1994) 5.37
Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell (1993) 5.28
The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell (1986) 5.13
Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro. Proc Natl Acad Sci U S A (1988) 4.40
Clonal diseases of large granular lymphocytes. Blood (1993) 3.75
Developmental hierarchy of immunoglobulin gene rearrangements in human leukemic pre-B-cells. Proc Natl Acad Sci U S A (1981) 3.73
BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein. Cell (1993) 2.92
Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia. Proc Natl Acad Sci U S A (1983) 2.73
Epstein-Barr virus strategy in normal and neoplastic B cells. Cell (1994) 2.63
p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies. Blood (1994) 2.51
Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma. N Engl J Med (1994) 2.50
Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. Proc Natl Acad Sci U S A (1994) 2.41
High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. Blood (1993) 2.34
Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice. EMBO J (1994) 2.33
Acute promyelocytic leukemia: from genetics to treatment. Blood (1994) 2.09
WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia. Blood (1994) 2.03
Chimeric homeobox gene E2A-PBX1 induces proliferation, apoptosis, and malignant lymphomas in transgenic mice. Cell (1993) 1.95
Absence of WAF1 mutations in a variety of human malignancies. Blood (1994) 1.95
Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia. Blood (1994) 1.91
BCL2 translocation frequency rises with age in humans. Proc Natl Acad Sci U S A (1994) 1.69
The nuclear tyrosine kinase c-Abl negatively regulates cell growth. Cell (1994) 1.62
Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia. Oncogene (1991) 1.56
Clinical importance of extraordinary integration patterns of human T-cell lymphotropic virus type I proviral DNA in adult T-cell leukemia/lymphoma. Blood (1994) 1.41
p53 mutations are associated with histologic transformation of follicular lymphoma. Blood (1993) 1.40
AIDS-related malignancies: the emerging epidemic. J Natl Cancer Inst (1993) 1.40
The retinoblastoma gene: role in cell cycle control and cell differentiation. FASEB J (1993) 1.39
Clustered mutations in the second exon of the MYC gene in sporadic Burkitt's lymphoma. Oncogene (1993) 1.39
p53 in hematologic malignancies. Blood (1994) 1.37
The t(1;19)(q23;p13) results in consistent fusion of E2A and PBX1 coding sequences in acute lymphoblastic leukemias. Blood (1991) 1.31
Single-cell analysis of Hodgkin and Reed-Sternberg cells: molecular heterogeneity of gene expression and p53 mutations. Blood (1993) 1.26
Current status of cytogenetic research in childhood acute lymphoblastic leukemia. Blood (1993) 1.25
Comparative genomic hybridization: an overview. Am J Pathol (1994) 1.23
Continuing rearrangement but absence of somatic hypermutation in immunoglobulin genes of human B cell precursor leukemia. J Exp Med (1988) 1.16
11q23/MLL rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemia. J Clin Oncol (1994) 1.16
African Burkitt's lymphoma. History, biology, clinical features, and treatment. Am J Pediatr Hematol Oncol (1991) 1.16
Persistence of the 8;21 translocation in patients with acute myeloid leukemia type M2 in long-term remission. Blood (1993) 1.15
Analysis of immunoglobulin and T cell receptor genes. Part II: Possibilities and limitations in the diagnosis and management of lymphoproliferative diseases and related disorders. Clin Chim Acta (1991) 1.15
Telomere shortening associated with disease evolution patterns in myelodysplastic syndromes. Cancer Res (1994) 1.13
Polymerase chain reaction versus Southern blot hybridization. Detection of immunoglobulin heavy-chain gene rearrangements. Diagn Mol Pathol (1995) 1.08
BCL-1/cyclin D1 oncoprotein oscillates and subverts the G1 phase control in B-cell neoplasms carrying the t(11;14) translocation. Oncogene (1994) 1.05
Somatic mutation in human B-cell tumors. Immunol Rev (1987) 1.03
How cells cycle toward cancer. Science (1994) 0.97
The incidence and prognostic significance of mutations in codon 13 of the N-ras gene in acute myeloid leukemia. Leukemia (1994) 0.96
RAR-alpha gene rearrangements as a genetic marker for diagnosis and monitoring in acute promyelocytic leukemia. Blood (1991) 0.96
Molecular evaluation of residual disease as a predictor of relapse in acute promyelocytic leukaemia. Lancet (1992) 0.95
Reverse transcription polymerase chain reaction for the rearranged retinoic acid receptor alpha clarifies diagnosis and detects minimal residual disease in acute promyelocytic leukemia. Proc Natl Acad Sci U S A (1992) 0.94
Early detection of relapse after bone marrow transplantation in patients with chronic myelogenous leukaemia. Lancet (1993) 0.93
Philadelphia-chromosome-positive adult acute lymphocytic leukemia: characteristics, treatment results, and prognosis in 41 patients. Am J Med (1994) 0.91
Clonal analysis of human tumors with M27 beta, a highly informative polymorphic X chromosomal probe. J Clin Invest (1992) 0.90
The Reed-Sternberg cells of Hodgkin disease are clonal. Proc Natl Acad Sci U S A (1994) 0.89
Cytogenetic analysis in the diagnosis of acute leukemia. Cancer (1992) 0.88
Minimal residual disease after bone marrow transplantation for multiple myeloma: evidence for cure in long-term survivors. Bone Marrow Transplant (1993) 0.87
Deletion of gene for multidrug resistance in acute myeloid leukaemia with inversion in chromosome 16: prognostic implications. Lancet (1994) 0.83
Cytogenetic studies, ras mutation, and clinical characteristics in primary myelodysplastic syndrome. A study on 68 Chinese patients in Taiwan. Cancer Genet Cytogenet (1994) 0.81
Variable IgH chain enhancer activity in Burkitt's lymphomas suggests an additional, direct mechanism of c-myc deregulation. J Immunol (1993) 0.81
Frequent detection of minimal residual disease by use of the polymerase chain reaction in long-term survivors after bone marrow transplantation for chronic myeloid leukemia. Leukemia (1990) 0.80
Inactivation of the retinoblastoma gene appears to be very uncommon in myelodysplastic syndromes. Br J Haematol (1994) 0.79
The prognostic value of cytogenetic analyses in patients with acute nonlymphocytic leukemia treated with the same intensive chemotherapy. Cancer (1992) 0.79
Minimal residual disease after bone marrow transplantation for chronic myelogenous leukemia and implications for graft-versus-leukemia effect: a review of recent results. Bone Marrow Transplant (1994) 0.78
Abnormalities of the retinoblastoma gene in the pathogenesis of acute leukemia. Blood (1991) 0.77
MDR1 RNA expression as a prognostic factor in acute myeloid leukemia: an update. Leuk Lymphoma (1993) 0.77
Attainment of molecular remission: a worthwhile goal? J Clin Oncol (1994) 0.77
Prognostic significance of loss of a chromosome 17p and p53 gene mutations in blast crisis of chronic myelogenous leukaemia. Br J Haematol (1994) 0.76
Fluorescence in situ hybridization in leukemia. Applications in diagnosis, subclassification, and monitoring the response to therapy. Ann N Y Acad Sci (1993) 0.76
The clinical application of molecular techniques in Philadelphia-positive leukaemia. Br J Haematol (1992) 0.76
Karyotype in myelodysplastic syndromes: relations to morphology, clinical evolution, and survival. Am J Hematol (1994) 0.76
Cell suicide: by ICE, not fire. Science (1994) 0.76